TICKERNERD
Menu
UNHUNHHealthcare · Healthcare Plans

UNH Stock Forecast: UnitedHealth Group, Inc. Price Predictions for 2026-2027

Last close, 11 Aug 2026
$402
−1.60% on the day

The 27 Wall Street analysts covering UnitedHealth Group, Inc. hold a median 12-month price target of $490 — +21.8% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 75 of 100 as at 10 Aug 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$365.4B
Ticker Nerd rank
75 / 100
Median analyst target
$490
Analysts covering
27
Total return, dividends reinvested
1W
−1.3%
1M
−5.3%
YTD
+23.5%
1Y
+63.6%
From 52W high
−7.8%
From 52W low
+63.6%
$246
$436
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

UNH stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores UnitedHealth Group, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 10 Aug 2026
75 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Revisions
94
Issuance
87
Volatility
83
Value
77
Momentum
67
Accruals
55
Quality
45
Growth
37
Size
1

Revisions (94): Analysts have, on balance, been raising their forecasts.

Growth (37): Sales and profits are flat, shrinking, or growing more slowly than they were.

Size (1): Larger than most of the companies we track — more scrutinised, less often mispriced.

Wall Street

UNH stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on UNH, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$200$250$300$350$400$450$500$550Oct 25Jan 26Apr 26Jul 26UNHHigh $529Median $490Low $313

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says27 analysts
22 Buy5 Hold0 Sell
Low $313Median $490High $529

The green dot is the last close — the median target sits +21.8% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 16 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
21 July 2026JP MorganMaintainsOverweight$466 → $516
21 July 2026MizuhoMaintainsOutperform$470 → $493
20 July 2026BarclaysMaintainsOverweight$429 → $441
17 July 2026KeybancMaintainsOverweight$475 → $500
17 July 2026Morgan StanleyMaintainsOverweight$468 → $529
17 July 2026OppenheimerMaintainsOutperform$420 → $500
17 July 2026RBC CapitalMaintainsOutperform$463 → $478
17 July 2026Truist SecuritiesMaintainsBuy$480 → $500
17 July 2026UBSMaintainsBuy$460 → $490
16 July 2026BairdUpgradeNeutral$287 → $453
14 July 2026KeybancMaintainsOverweight$400 → $475
14 July 2026TD CowenMaintainsHold$337 → $430
14 July 2026Truist SecuritiesMaintainsBuy$440 → $480
13 July 2026Wells FargoMaintainsOverweight—
13 July 2026Wells FargoMaintainsOverweight$397 → $485
9 July 2026RBC CapitalMaintainsOutperform$400 → $463
9 July 2026RBC CapitalMaintainsOutperform—
6 July 2026HSBCMaintainsHold$300 → $380
6 July 2026HSBCMaintainsHold—
30 June 2026Morgan StanleyMaintainsOverweight—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. UNH appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

UNH analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+7.9%
Analysts raising
24
Analysts cutting
0
Fundamentals

UnitedHealth Group, Inc. (UNH) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
30.3×

Cheaper than 27% of US stocks

Price / sales
0.8×

Cheaper than 74% of US stocks

Price / book
3.5×

Cheaper than 30% of US stocks

EV / EBITDA
17.0×

Cheaper than 20% of US stocks

Growth & margins
Revenue growth (YoY)
0.4%

Higher than 28% of US stocks

Earnings growth (YoY)
61.0%

Higher than 79% of US stocks

Gross margin
22.7%

Higher than 25% of US stocks

Operating margin
7.1%

Higher than 59% of US stocks

Net margin
3.1%

Higher than 55% of US stocks

Returns & dividend
Return on equity
14.2%

Higher than 73% of US stocks

Return on assets
4.4%

Higher than 73% of US stocks

Dividend yield
2.3%

Higher than 52% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

UNH vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealthcare Plans
CompanyMarket capTKN rank
UNHUnitedHealth Group, Inc.$365.4B
75
CVSCVS Health Corp.$121.4B
86
ELVElevance Health, Inc.$88.4B
66
CIThe Cigna Group$73.6B
70
HUMHumana, Inc.$46.4B
42
CNCCentene Corp.$32.7B
93
MRKMerck & Co., Inc.*$324.9B
55

* Nearest Healthcare names by size — few healthcare plans companies of this scale trade in the US universe.

The rank is the raw material. Whether the rules would actually own UnitedHealth Group, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest UNH news & analysis

UnitedHealth's Medicare Recovery Is Accelerating And Has More Room To Run

Seeking Alpha · 11 Aug 2026positive

UnitedHealth's Medicare Advantage recovery is accelerating, with cost trends running below the original 10% assumption and 2026 Medicare margins expected to exceed 3%. The company raised its UnitedHealthcare operating earnings outlook to at least $12 billion and lifted its adjusted EPS guidance to $19.50–$20.

Why it matters — The raised earnings outlook and improving Medicare cost trends signal strengthening performance in UnitedHealth's key Medicare business, a core focus for investors tracking the company.

Why UnitedHealth Group (UNH) is a Top Value Stock for the Long-Term

Zacks Investment Research · 7 Aug 2026positive

A Zacks Investment Research article highlights UnitedHealth Group as a top value stock for the long-term, using its Style Scores tool to identify top-rated stocks based on investing style.

Why it matters — This suggests that UNH is viewed favorably by an investment research firm for value-oriented, long-term investors.

4 Healthcare Stocks to Watch as Defensive Demand Strengthens

Zacks Investment Research · 7 Aug 2026positive

According to Zacks Investment Research, healthcare's defensive demand is strengthening in 2026, and UNH is named among four healthcare stocks (alongside BTSG, HRMY, and NVCR) that stand out on improving earnings outlooks and steady sector momentum.

Why it matters — UNH watchers would care because the item highlights UnitedHealth as a notable healthcare stock benefiting from strengthening defensive demand and an improving earnings outlook.

Brown Advisory Flexible Equity Strategy Q2 2026 Portfolio Activity

Seeking Alpha · 5 Aug 2026neutral

Brown Advisory's Flexible Equity Strategy reported Q2 2026 portfolio activity, noting Taiwan Semiconductor traded higher on strong results and guidance, Intuit declined on lower-than-expected DIY tax franchise growth, and the fund initiated a position in Capital One Financial.

Why it matters — The item covers another fund manager's quarterly moves and contains no mention of UnitedHealth or its sector, so UNH watchers get no direct signal from it.

Is UnitedHealth Stock Still a Buy in August After Its Q2 Beat Last Month?

24/7 Wall Street · 5 Aug 2026positive

UnitedHealth Group reported Q2 2026 results on July 16 that surpassed Wall Street's expectations, even exceeding the higher end of analysts' estimates.

Why it matters — The earnings beat signals that UnitedHealth's financial performance continues to exceed analyst forecasts, which could influence investor sentiment toward the stock.

FAQ

Frequently asked questions about UNH stock

What is the UNH stock price forecast for 2026-2027?

The 27 Wall Street analysts covering UnitedHealth Group, Inc. have a median 12-month price target of $490, with estimates ranging from $313 to $529. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is UNH stock a buy right now?

Of the 27 analysts covering UnitedHealth Group, Inc., 22 rate it a Buy, 5 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks UnitedHealth Group, Inc. 75 out of 100 across roughly 4,600 US stocks as at 10 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank UNH?

As at 10 Aug 2026, UnitedHealth Group, Inc. ranks 75 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (94 of 100).

Will UNH stock go up?

No one can know that. What the data says: the median 12-month target from 27 analysts implies +21.8% from the last close, and Ticker Nerd's factor model ranks UnitedHealth Group, Inc. 75 out of 100 as at 10 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the UNH stock forecast for 2030?

No analyst covering UnitedHealth Group, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for UNH are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $313 to $529 over the next 12 months.

How has UNH stock performed over the past year?

UnitedHealth Group, Inc. returned +63.6% over the 12 months to 11 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does UnitedHealth Group, Inc. do?

UnitedHealth Group Incorporated is a diversified health care company that provides health benefit plans, medical services, pharmacy care, and health technology solutions. Through UnitedHealthcare, it offers coverage for individuals, employers, Medicare and Medicaid beneficiaries, supporting access to care through broad provider networks and member services.

What is the latest news on UNH?

The most recent item we track (Seeking Alpha, 11 Aug 2026): "UnitedHealth's Medicare Recovery Is Accelerating And Has More Room To Run". UnitedHealth's Medicare Advantage recovery is accelerating, with cost trends running below the original 10% assumption and 2026 Medicare margins expected to exceed 3%. The company raised its UnitedHealthcare operating earnings outlook to at least $12 billion and lifted its adjusted EPS guidance to $19.50–$20.

Company

About UnitedHealth Group, Inc.

UnitedHealth Group Incorporated is a diversified health care company that provides health benefit plans, medical services, pharmacy care, and health technology solutions. Through UnitedHealthcare, it offers coverage for individuals, employers, Medicare and Medicaid beneficiaries, supporting access to care through broad provider networks and member services. Its Optum businesses deliver care delivery, pharmacy benefit management, data analytics, consulting, and software tools that support hospitals, physicians, payers, and public-sector clients. The company serves consumers, health care professionals, employers, and government organizations across the United States and internationally, making it a major participant in managed care and health services. UnitedHealth Group Incorporated plays a central role in connecting insurance, clinical care, and data-driven operations within the health care market.

CEO Mr. Stephen J. Hemsley · 390,000 employees · United States · https://www.unitedhealthgroup.com